Top Markets
Coin of the day
PharmaBlock Sciences (Nanjing), Inc. PharmaBlock Sciences (Nanjing), Inc.

PharmaBlock Sciences (Nanjing), Inc.

300725
Rank in Stocks #7576
PharmaBlock Sciences (Nanjing), Inc. delivers a comprehensive suite of chemical... PharmaBlock Sciences (Nanjing), Inc. delivers a comprehensive suite of chemical products and specialized services, supporting the pharmaceutical industry across the full spectrum of its operations – from initial research and development phases to large-scale commercial production. The company's primary offerings encompass: A vast inventory of chemical building blocks, available for supply at every stage of drug creation, from early discovery through to advanced development and commercial manufacturing. The creation of diverse chemical libraries, derived from their building blocks, specifically designed to accelerate drug discovery processes. Contract development and manufacturing (CDMO) services for essential pharmaceutical components, including raw starting materials (RSMs), chemical intermediates, active pharmaceutical ingredients (APIs), and finished drug products, catering to both clinical development programs and market demands. Established in 2006, PharmaBlock Sciences maintains its corporate headquarters in Nanjing, People's Republic of China.
Share Price
$6.59
Market Cap
$1.54B
Change (1 day)
-2.84%
Change (1 year)
9.06%
Country
CN
Trade PharmaBlock Sciences (Nanjing), Inc. (300725)

Category

Number of shares outstanding for PharmaBlock Sciences (Nanjing), Inc. (300725)
Number of shares outstanding as of August 2026: 0
According to PharmaBlock Sciences (Nanjing), Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for PharmaBlock Sciences (Nanjing), Inc. (300725) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors